Nagase FN, Fukui S, Takizawa N, Yamaguchi T, et al. Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events. J Rheumatol 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612.
PMID: 39547687